Using recency assays for HIV surveillance — 2022 technical guidance

This technical guidance outlines best practices regarding the appropriate use of HIV recency assays for surveillance purposes within population-based surveys for estimating HIV incidence; and Programme data from HIV testing services for population- or programme-level monitoring.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

Using recency assays for HIV surveillance — 2022 technical guidance

Distribution channels: Human Rights

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.